Previous Article | Next Article 
Journal of Virology, October 1998, p. 8257-8263, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Herpes Simplex Virus Type 1 Glycoprotein gC
Mediates Immune Evasion In Vivo
John M.
Lubinski,1
Liyang
Wang,1
Athena M.
Soulika,2
Reinhard
Burger,3
Rick A.
Wetsel,4,
Harvey
Colten,4,
Gary H.
Cohen,5
Roselyn J.
Eisenberg,6
John D.
Lambris,2 and
Harvey
M.
Friedman1,*
Departments of
Medicine1 and
Pathology,2 School of Medicine,
Department of Microbiology, School of Dental
Medicine,5 and
Veterinary
Medicine,6 University of Pennsylvania,
Philadelphia, Pennsylvania;
Robert Koch Institut, Berlin,
Germany3; and
Department of Pediatrics,
School of Medicine, Washington University, St. Louis,
Missouri4
Received 12 May 1998/Accepted 25 June 1998
Many microorganisms encode proteins that interact with molecules
involved in host immunity; however, few of these molecules have been
proven to promote immune evasion in vivo. Herpes simplex virus type 1 (HSV-1) glycoprotein C (gC) binds complement component C3 and inhibits
complement-mediated virus neutralization and lysis of infected cells in
vitro. To investigate the importance of the interaction between gC and
C3 in vivo, we studied the virulence of a gC-null strain in
complement-intact and C3-deficient animals. Using a vaginal infection
model in complement-intact guinea pigs, we showed that gC-null virus
grows to lower titers and produces less severe vaginitis than wild-type
or gC rescued virus, indicating a role for gC in virulence. To
determine the importance of complement, studies were performed with
C3-deficient guinea pigs; the results demonstrated significant
increases in vaginal titers of gC-null virus, while wild-type and gC
rescued viruses showed nonsignificant changes in titers. Similar
findings were observed for mice where gC null virus produced
significantly less disease than gC rescued virus at the skin
inoculation site. Proof that C3 is important was provided by studies of
C3 knockout mice, where disease scores of gC-null virus were
significantly higher than in complement-intact mice. The results
indicate that gC-null virus is approximately 100-fold (2 log10) less virulent that wild-type virus in animals and
that gC-C3 interactions are involved in pathogenesis.
*
Corresponding author. Mailing address: 536 Johnson
Pavilion, University of Pennsylvania, Philadelphia, PA 19104-6073. Phone: (215) 662-2473. Fax: (215) 349-5111. E-mail:
hfriedma{at}mail.med.upenn.edu.
Present address: Institute of Molecular Medicine for Prevention of
Human Diseases, University of Texas, Houston, TX 77030.

Present address: Northwestern University Medical School, Chicago,
IL 60611.
Journal of Virology, October 1998, p. 8257-8263, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Meckes, D. G. Jr., Wills, J. W.
(2008). Structural Rearrangement within an Enveloped Virus upon Binding to the Host Cell. J. Virol.
82: 10429-10435
[Abstract]
[Full Text]
-
Sedlackova, L., Perkins, K. D., Lengyel, J., Strain, A. K., van Santen, V. L., Rice, S. A.
(2008). Herpes Simplex Virus Type 1 ICP27 Regulates Expression of a Variant, Secreted Form of Glycoprotein C by an Intron Retention Mechanism. J. Virol.
82: 7443-7455
[Abstract]
[Full Text]
-
Hook, L. M., Huang, J., Jiang, M., Hodinka, R., Friedman, H. M.
(2008). Blocking Antibody Access to Neutralizing Domains on Glycoproteins Involved in Entry as a Novel Mechanism of Immune Evasion by Herpes Simplex Virus Type 1 Glycoproteins C and E. J. Virol.
82: 6935-6941
[Abstract]
[Full Text]
-
Girgis, N. M., DeHaven, B. C., Fan, X., Viner, K. M., Shamim, M., Isaacs, S. N.
(2008). Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack. J. Virol.
82: 4205-4214
[Abstract]
[Full Text]
-
Orlando, J. S., Balliet, J. W., Kushnir, A. S., Astor, T. L., Kosz-Vnenchak, M., Rice, S. A., Knipe, D. M., Schaffer, P. A.
(2006). ICP22 Is Required for Wild-Type Composition and Infectivity of Herpes Simplex Virus Type 1 Virions. J. Virol.
80: 9381-9390
[Abstract]
[Full Text]
-
Hook, L. M., Lubinski, J. M., Jiang, M., Pangburn, M. K., Friedman, H. M.
(2006). Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin m antibody.. J. Virol.
80: 4038-4046
[Abstract]
[Full Text]
-
Lee, L. Y. L., Liang, X., Hook, M., Brown, E. L.
(2004). Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb). J. Biol. Chem.
279: 50710-50716
[Abstract]
[Full Text]
-
Judson, K. A., Lubinski, J. M., Jiang, M., Chang, Y., Eisenberg, R. J., Cohen, G. H., Friedman, H. M.
(2003). Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection. J. Virol.
77: 12639-12645
[Abstract]
[Full Text]
-
Favoreel, H. W., Van de Walle, G. R., Nauwynck, H. J., Pensaert, M. B.
(2003). Virus complement evasion strategies. J. Gen. Virol.
84: 1-15
[Abstract]
[Full Text]
-
Brockman, M. A., Knipe, D. M.
(2002). Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity. J. Virol.
76: 3678-3687
[Abstract]
[Full Text]
-
Verschoor, A., Brockman, M. A., Knipe, D. M., Carroll, M. C.
(2001). Cutting Edge: Myeloid Complement C3 Enhances the Humoral Response To Peripheral Viral Infection. J. Immunol.
167: 2446-2451
[Abstract]
[Full Text]
-
Kingham, B. F., Zelnik, V., Kopácek, J., Majerciak, V., Ney, E., Schmidt, C. J.
(2001). The genome of herpesvirus of turkeys: comparative analysis with Marek's disease viruses. J. Gen. Virol.
82: 1123-1135
[Abstract]
[Full Text]
-
Friedman, H. M., Wang, L., Pangburn, M. K., Lambris, J. D., Lubinski, J.
(2000). Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1. J. Immunol.
165: 4528-4536
[Abstract]
[Full Text]
-
Saldanha, C. E., Lubinski, J., Martin, C., Nagashunmugam, T., Wang, L., van der Keyl, H., Tal-Singer, R., Friedman, H. M.
(2000). Herpes Simplex Virus Type 1 Glycoprotein E Domains Involved in Virus Spread and Disease. J. Virol.
74: 6712-6719
[Abstract]
[Full Text]
-
Ikeda, K., Wakimoto, H., Ichikawa, T., Jhung, S., Hochberg, F. H., Louis, D. N., Chiocca, E. A.
(2000). Complement Depletion Facilitates the Infection of Multiple Brain Tumors by an Intravascular, Replication-Conditional Herpes Simplex Virus Mutant. J. Virol.
74: 4765-4775
[Abstract]
[Full Text]
-
Murray, I., Havel, P. J., Sniderman, A. D., Cianflone, K.
(2000). Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein. Endocrinology
141: 1041-1049
[Abstract]
[Full Text]
-
Friedman, H. M., Hartley, C., Corey, L., Langenberg, A. G. M., Burke, R. L., Straus, S., Mascola, J. R.
(2000). Immunologic Strategies for Herpes Vaccination. JAMA
283: 746-746
[Full Text]
-
Murray, I., Sniderman, A. D., Havel, P. J., Cianflone, K.
(1999). Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice. J. Biol. Chem.
274: 36219-36225
[Abstract]
[Full Text]
-
Lubinski, J., Wang, L., Mastellos, D., Sahu, A., Lambris, J. D., Friedman, H. M.
(1999). In Vivo Role of Complement-Interacting Domains of Herpes Simplex Virus Type 1 Glycoprotein Gc. JEM
190: 1637-1646
[Abstract]
[Full Text]
-
Da Costa, X. J., Brockman, M. A., Alicot, E., Ma, M., Fischer, M. B., Zhou, X., Knipe, D. M., Carroll, M. C.
(1999). Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. USA
96: 12708-12712
[Abstract]
[Full Text]
-
Murray, I., Sniderman, A. D., Cianflone, K.
(1999). Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J. Lipid Res.
40: 1671-1676
[Abstract]
[Full Text]
-
Kapadia, S. B., Molina, H., van Berkel, V., Speck, S. H., Virgin, H. W. IV
(1999). Murine Gammaherpesvirus 68 Encodes a Functional Regulator of Complement Activation. J. Virol.
73: 7658-7670
[Abstract]
[Full Text]